At a glance
- Originator Takeda
- Class Urologics
- Mechanism of Action Acetylcholinesterase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Urinary incontinence
Most Recent Events
- 29 Apr 2005 Discontinued - Phase-II for Urinary incontinence in Japan (unspecified route)
- 05 Apr 2004 A preclinical study has been added to the pharmacokinetics and Genitourinary Disorders pharmacodynamics sections
- 10 Nov 2003 Phase-II clinical trials in urinary incontinence in Japan (unspecified route)